{rfName}
Or

Indexed in

License and use

Citations

24

Altmetrics

Analysis of institutional authors

Alcobendas Rueda, Rosa MCorresponding AuthorLópez A.Author
Share
Publications
>
Article

Oral Versus Intravenous Antibiotics for Pediatric Osteoarticular Infection: When and to Whom?

Publicated to:PEDIATRIC INFECTIOUS DISEASE JOURNAL. 41 (9): E351-E357 - 2022-09-01 41(9), DOI: 10.1097/INF.0000000000003619

Authors: Alcobendas Rueda, Rosa M; Nunez, Esmeralda; Martin, Laura; Belen Hernandez, Maria; Saavedra-Lozano, Jesus; Udaondo, Clara; Murias, Sara; Remesal, Agustin; Calvo, Cristina

Affiliations

Hosp Maternoinfantil, Pediat Dept, Malaga, Spain - Author
Hosp Univ La Paz, Pediat Infect Dis Dept, Madrid, Spain - Author
Hosp Univ La Paz, Pediat Rheumatol Unit, Madrid, Spain - Author
Hosp Univ Sureste, Pediat Dept, Madrid, Spain - Author
Med Complutense Univ, Madrid, Spain - Author
Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Pediat Infect Dis Unit, Madrid, Spain - Author
See more

Abstract

Background: Osteoarticular infections (OAIs) are typically treated initially with intravenous antibiotics. The objective of this study was to evaluate whether an exclusive oral treatment in selected children may be appropriate. Methods: The Spanish Network of Osteoarticular Infections is a nationwide multicenter registry comprising 37 hospitals in Spain. The registry prospectively includes clinical characteristics and outcome of children with OAI. One of the hospitals from RioPed offers oral treatment to children meeting certain criteria. Patients were classified into 2 groups. Group 1: management with initial intravenous antibiotic therapy. Group 2: patients exclusively treated with oral antibiotics. A comparison between the 2 groups was performed. Results: We compared 893 children who initially received intravenous antibiotics (group 1) with 64 children who received exclusively oral therapy (group 2). Patients from group 2 were younger (33.9 vs. 20.3 months; P = 0.001), had a lower percentage of Staphylococcus aureus (23.3% vs. 3.1%; P < 0.001), a higher proportion of Kingella kingae (12.1% vs. 28.1%; P = 0.001), higher erythrocyte sedimentation rate/C-reactive protein (CRP) ratio (1.4 interquartile range 0.6-3.6 vs. 3.3 interquartile range 1.7-5.7; P < 0.001) and showed lower rate of fever (63% vs. 48.8%; P = 0.024) than in group 1. Complications were not found in group 2. Conclusions: An exclusively oral administration could be a safe option in selected patients with OAI. Low-risk criteria are proposed: good general condition, no underlying disease, 6 months to 3 years old, appropriate oral tolerance, C-reactive protein = 0.67, no skin injury, no recent surgery, no cervical spondylodiscitis and no local complications at onset.

Keywords

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal PEDIATRIC INFECTIOUS DISEASE JOURNAL due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 23/130, thus managing to position itself as a Q1 (Primer Cuartil), in the category Pediatrics.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 1.81. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

This information is reinforced by other indicators of the same type, which, although dynamic over time and dependent on the set of average global citations at the time of their calculation, consistently position the work at some point among the top 50% most cited in its field:

  • Weighted Average of Normalized Impact by the Scopus agency: 2.45 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 7.48 (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-15, the following number of citations:

  • WoS: 8
  • Scopus: 12
  • Europe PMC: 4
  • OpenCitations: 11
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-15:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 20.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 20 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 27.88.
  • The number of mentions on the social network X (formerly Twitter): 33 (Altmetric).
Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (ALCOBENDAS RUEDA, ROSA MARIA) .

the author responsible for correspondence tasks has been ALCOBENDAS RUEDA, ROSA MARIA.